Literature DB >> 9353865

Bile acids, oxidative stress, and renal function in biliary obstruction.

A Bomzon1, S Holt, K Moore.   

Abstract

Renal dysfunction occurs in patients with biliary obstruction. Plasma accumulation of bile acids and oxidative stress have been proposed as contributory factors. Bile acids can alter the renal handling of electrolytes and water by blocking the Na(+)-H+ antiport in the tubule. Oxidative stress, defined as an imbalance between radical generating systems and radical scavenging systems giving rise to free radical induced tissue damage, occurs in patients with liver disease. Bile acids cause oxidative damage to tubular cell membranes by stimulating the generation of oxygen free radicals from mitochondria, as well as promoting their release from neutrophils and macrophages. Oxidative stress can promote the formation of a variety of vasoactive mediators including endothelin-1, cysteinyl leukotrienes, as well as the F2-isoprostanes, endogenous products of lipid peroxidation. These mediators can each affect renal function directly by causing renal vasoconstriction or decreasing the glomerular capillary ultrafiltration coefficient, and thus reduce glomerular filtration rate. Collectively, these factors contribute to the onset of renal failure in patients with biliary obstruction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9353865

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  31 in total

1.  Lack of bilirubin removal during dialysis without an impact on creatinine clearance.

Authors:  N Khoury; G Pelle; M A Costa; E Rondeau
Journal:  Pediatr Nephrol       Date:  2003-10-15       Impact factor: 3.714

2.  Participation of nuclear factor (erythroid 2-related), factor 2 in ameliorating lithocholic acid-induced cholestatic liver injury in mice.

Authors:  K P Tan; G A Wood; M Yang; S Ito
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

3.  Magnesium lithospermate B improves the gut microbiome and bile acid metabolic profiles in a mouse model of diabetic nephropathy.

Authors:  Jing Zhao; Qing-Li Zhang; Jian-Hua Shen; Kai Wang; Jia Liu
Journal:  Acta Pharmacol Sin       Date:  2018-06-25       Impact factor: 6.150

4.  Effect of heme oxygenase-1 on renal function in rats with liver cirrhosis.

Authors:  Shi-Bin Guo; Zhi-Jun Duan; Qing Li; Xiao-Yu Sun
Journal:  World J Gastroenterol       Date:  2011-01-21       Impact factor: 5.742

5.  Preventing oxygen free radical damage by proanthocyanidin in obstructive jaundice.

Authors:  Mervan Savdan; Murat Çakır; Hüsamettin Vatansev; Tevfik Küçükkartallar; Ahmet Tekin; Şakir Tavlı
Journal:  Turk J Surg       Date:  2017-06-01

6.  Taurocholic acid prevents biliary damage induced by hepatic artery ligation in cholestatic rats.

Authors:  Shannon Glaser; Paolo Onori; Eugenio Gaudio; Yoshiyuki Ueno; Luigi Pannarale; Antonio Franchitto; Heather Francis; Romina Mancinelli; Guido Carpino; Julie Venter; Mellanie White; Shelley Kopriva; Antonella Vetuschi; Roberta Sferra; Gianfranco Alpini
Journal:  Dig Liver Dis       Date:  2010-03-20       Impact factor: 4.088

7.  Evidence of a systemic phenomenon for oxidative stress in cholestatic liver disease.

Authors:  P Ljubuncic; Z Tanne; A Bomzon
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

Review 8.  Meta-analysis of survival with the molecular adsorbent recirculating system for liver failure.

Authors:  Guo-Lin He; Lei Feng; Chong-Yang Duan; Xiang Hu; Chen-Jie Zhou; Yuan Cheng; Ming-Xin Pan; Yi Gao
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 9.  Bile-acid-induced cell injury and protection.

Authors:  Maria-J Perez; Oscar Briz
Journal:  World J Gastroenterol       Date:  2009-04-14       Impact factor: 5.742

10.  Apoptosis-inducing factor plays a role in the pathogenesis of hepatic and renal injury during cholestasis.

Authors:  Vahid Ghanbarinejad; Akram Jamshidzadeh; Bahman Khalvati; Omid Farshad; Huifeng Li; Xiong Shi; Yuanyu Chen; Mohammad Mehdi Ommati; Reza Heidari
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-02-01       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.